Vulnerability Description
A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Beckmancoulter | Remisol Advance | <= 2.0.12.1 |
Related Weaknesses (CWE)
References
- https://pastebin.com/amgw9pE7Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/reProductVendor Advisory
- https://pastebin.com/amgw9pE7Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/reProductVendor Advisory
FAQ
What is CVE-2022-26235?
CVE-2022-26235 is a vulnerability with a CVSS score of 7.8 (HIGH). A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrit...
How severe is CVE-2022-26235?
CVE-2022-26235 has been rated HIGH with a CVSS base score of 7.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2022-26235?
Check the references section above for vendor advisories and patch information. Affected products include: Beckmancoulter Remisol Advance.